DMAARDrugs Made In America Acquisition Corp.vs its industry peers
A metric-by-metric comparison of Drugs Made In America Acquisition Corp. against SIC 6770 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMAARThis | $3M#6 | — | — | — | — | — | — | — | — | — | -34.9%#1 | — |
| FGIIW | $5M#1 | — | 5.6x#3 | — | — | — | — | 0.0%#1 | — | — | — | — |
| DMIIR | $5M#2 | — | — | — | — | — | — | — | — | — | — | — |
| SSACR | $3M#3 | — | — | — | — | — | — | — | — | — | — | — |
| FMACR | $3M#4 | — | 5.7x#4 | — | — | — | — | 0.0%#1 | — | — | — | — |
| CTAAR | $3M#5 | — | 1.8x#1 | — | — | — | — | 0.0%#1 | — | — | — | — |
| MYXXR | $2M#7 | — | 10.6x#5 | — | — | — | — | 0.0%#1 | — | — | — | — |
| APMCR | $2M#8 | — | 3.0x#2 | — | — | — | — | 0.0%#1 | — | — | — | — |
| MCAHR | $2M#9 | — | — | — | — | — | — | — | — | — | — | — |
| FXACW | $2M#10 | — | — | — | — | — | — | — | — | — | — | — |
| EWAVR | $2M#11 | — | — | — | — | — | — | — | — | — | — | — |
| COLAR | $2M#12 | — | — | — | — | — | — | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 6770). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice